| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
5
4
3
1
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
4 / 5 Stars
|
|
TheStreet.com
B+
(Buy)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 6.71 | 6.71 |
| Stocks | 76.19 | 76.19 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 17.1 | 17.1 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Gilead Sciences Inc | GILD | 36.53 | 3.2 |
| NXP Semiconductor NV | NXPI | 1.67 | 2.77 |
| American International Group Inc | AIG | 16.69 | 2.75 |
| Eastman Chemical Company | EMN | -5.42 | 2.68 |
| LyondellBasell Industries NV | LYB | 1.49 | 2.57 |
| Qualcomm, Inc. | QCOM | 0.5 | 2.29 |
| HollyFrontier Corp | HFC | 4.85 | 2.27 |
| Salesforce.com, Inc. | CRM | -1.11 | 2.22 |
| Biogen Idec Inc | BIIB | 46.43 | 2.12 |
| Las Vegas Sands Corp | LVS | 22.62 | 2.05 |
